Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jurij Hanzel

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Journal of Clinical Medicine|November 26, 2022
Contemporary Management of Postoperative Crohn's Disease after Ileocolonic ResectionJurij Hanzel, David Drobne
Immunotherapy|July 19, 2023
Mirikizumab for the treatment of moderate to severe ulcerative colitisJurij Hanzel, Christopher Ma, Vipul Jairath
Cureus|July 10, 2020
Metastatic Gastric Signet Ring Cell Adenocarcinoma Presenting With Colonic StenosisJurij Hanzel, Branislava Ranković, Marija Ribnikar
Immunotherapy|February 16, 2024
Upadacitinib for the treatment of moderate-to-severe Crohn's diseaseJurij Hanzel, Christopher Ma, Vipul Jairath
Expert Opinion on Biological Therapy|December 1, 2025
An evaluation of guselkumab for the treatment of ulcerative colitisJurij Hanzel, Vipul Jairath, Brian G Feagan
Expert Review of Clinical Immunology|April 28, 2022
Emerging therapies for ulcerative colitisJurij Hanzel, Melanie S Hulshoff, Joep Grootjans, et al.
Radiology and Oncology|May 29, 2020
Sorafenib for the treatment of hepatocellular carcinoma: a single-centre real-world studyJurij Hanzel, Tajda Kosir Bozic, Borut Stabuc, et al.
European Journal of Gastroenterology & Hepatology|August 29, 2020
Survival outcomes and rate of missed upper gastrointestinal cancers at routine endoscopy: a single centre retrospective cohort studyAleksandar Gavric, Jurij Hanzel, Tina Zagar, et al.
Drugs|May 5, 2025
Differentiating IL-23 Inhibitors in Crohn's DiseaseOlga Maria Nardone, Sudheer K Vuyyuru, Yuhong Yuan, et al.
Crohn'S & Colitis 360|July 1, 2024
Differences Between the 2016 and 2022 Food and Drug Administration Guidance-Implications for Design and Interpretation of Clinical Trials in Ulcerative ColitisJurij Hanzel, Christopher Ma, Laurent Peyrin-Biroulet, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Journal of Clinical Medicine|November 26, 2022
Contemporary Management of Postoperative Crohn's Disease after Ileocolonic ResectionJurij Hanzel, David Drobne
Immunotherapy|July 19, 2023
Mirikizumab for the treatment of moderate to severe ulcerative colitisJurij Hanzel, Christopher Ma, Vipul Jairath
Cureus|July 10, 2020
Metastatic Gastric Signet Ring Cell Adenocarcinoma Presenting With Colonic StenosisJurij Hanzel, Branislava Ranković, Marija Ribnikar
Immunotherapy|February 16, 2024
Upadacitinib for the treatment of moderate-to-severe Crohn's diseaseJurij Hanzel, Christopher Ma, Vipul Jairath
Expert Opinion on Biological Therapy|December 1, 2025
An evaluation of guselkumab for the treatment of ulcerative colitisJurij Hanzel, Vipul Jairath, Brian G Feagan
Expert Review of Clinical Immunology|April 28, 2022
Emerging therapies for ulcerative colitisJurij Hanzel, Melanie S Hulshoff, Joep Grootjans, et al.
Radiology and Oncology|May 29, 2020
Sorafenib for the treatment of hepatocellular carcinoma: a single-centre real-world studyJurij Hanzel, Tajda Kosir Bozic, Borut Stabuc, et al.
European Journal of Gastroenterology & Hepatology|August 29, 2020
Survival outcomes and rate of missed upper gastrointestinal cancers at routine endoscopy: a single centre retrospective cohort studyAleksandar Gavric, Jurij Hanzel, Tina Zagar, et al.
Drugs|May 5, 2025
Differentiating IL-23 Inhibitors in Crohn's DiseaseOlga Maria Nardone, Sudheer K Vuyyuru, Yuhong Yuan, et al.
Crohn'S & Colitis 360|July 1, 2024
Differences Between the 2016 and 2022 Food and Drug Administration Guidance-Implications for Design and Interpretation of Clinical Trials in Ulcerative ColitisJurij Hanzel, Christopher Ma, Laurent Peyrin-Biroulet, et al.
Pageof 5